For anyone who lost a job and is worrying about how they might pay the March mortgage, you have company.
The turnover of chief executive officers in January was the highest its been since May 2010 and health-care chiefs led the way out the door.
Challenger, Gray & Christmas, Inc., which calls itself the "original outplacement company," said in its monthly report that 123 CEOs left their jobs in January, the most since 125 departed in May 2010. In January of 2011, 96 CEOs left their jobs, one way or another.
Twenty five health-care CEOs departed the top spot this year, up from nine in January of last year.
Challenger said that health-care organizations topped all sectors in turnover in 2011, with 187 CEOs bidding adieu, an average of 15.6 per month.
A couple prominent global pharmaceutical companies, with big local operations, more or less started the last two years with new leaders.
Within a week late in November and early December of 2010, Merck and Pfizer said they would change chiefs.
On. Nov. 30, 2010, Merck named Philly-native Kenneth C. Frazier to succeed Richard T. Clark.
On. Dec. 5, 2010, Pfizer said Ian Read would replace Jeffrey Kindler.
On Jan. 1, 2012, Teva said Shlomo Yanai would step down to be replaced by Jeremy Levin.
David Sell covers the pharmaceutical industry and related topics for The Inquirer’s Business Department. David has been a reporter and editor for more than 20 years. Contact him with tips and suggestions about news from the drug industry and the people who define an industry that touches nearly everyone and employs tens of thousands in the Philadelphia area. David can be reached at 215-854-4506 or dsell@phillynews.com.
You can also follow David on Twitter here.
Like David Sell and PhillyPharma on Facebook here.
- Pharmalot
- The Placebo Effect
- New York Times/Prescriptions
- Wall Street Journal/Health blog
- Financial Times
- Cafe Pharma
- Pharma Marketing
- Bio Century
- Bio Space
- Pharma Live
- Monday Morning
- In The Pipeline
- U.S. Department of Health and Human Services
- Food and Drug Administration
- Centers for Medicare and Medicaid
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Centers for Disease Control and Prevention
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- Clinical Trials
- Pharmaceutical Research and Manufacturers of America
- BIO
- Pennsylvania Association of Medical Suppliers
- Jersey Association of Medical Equipment Services
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West